Association of systemic lupus erythematosus with a higher risk of cervical but not trochanteric hip fracture: A nationwide population-based study

Arthritis Care and Research

Volumn 65, Issue 10, 2013, Pages 1674-1681

  Wang, Shu Hung ^a   Chang, Yu Sheng ^b   Liu, Chia Jen ^a   Lai, Chien Chih ^a   Chen, Wei Sheng ^a   Chen, Tzeng Ji ^a   Wang, Shuu Jiun ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HYDROXYCHLOROQUINE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PARATHYROID HORMONE[1-34]; PREDNISOLONE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; STEROID; WARFARIN;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CERVICAL SPINE FRACTURE; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; FEMALE; FEMUR TROCHANTERIC FRACTURE; HIP FRACTURE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH INSURANCE; OSTEOPOROSIS; PHASE 1 CLINICAL TRIAL; RISK ASSESSMENT; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; TAIWAN;

ADULT; CASE-CONTROL STUDIES; CERVICAL VERTEBRAE; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; FEMALE; HIP FRACTURES; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SPINAL FRACTURES; TAIWAN; TIME FACTORS; YOUNG ADULT;

EID: 84885004500     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22028     Document Type: Article

References (42)

1. Ramsey-Goldman R, Dunn JE, Huang CF, Dunlop D, Rairie JE, Fitzgerald S, et al. Frequency of fractures in women with systemic lupus erythematosus: comparison with United States population data. Arthritis Rheum 1999; 42: 882-90.
2. Yee CS, Crabtree N, Skan J, Amft N, Bowman S, Situnayake D, et al. Prevalence and predictors of fragility fractures in systemic lupus erythematosus. Ann Rheum Dis 2005; 64: 111-3.
3. Shao CJ, Hsieh YH, Tsai CH, Lai KA,. A nationwide seven-year trend of hip fractures in the elderly population of Taiwan. Bone 2009; 44: 125-9.
4. Duboeuf F, Hans D, Schott AM, Kotzki PO, Favier F, Marcelli C, et al. Different morphometric and densitometric parameters predict cervical and trochanteric hip fracture: the EPIDOS Study. J Bone Miner Res 1997; 12: 1895-902.
5. Gnudi S, Ripamonti C, Lisi L, Fini M, Giardino R, Giavaresi G,. Proximal femur geometry to detect and distinguish femoral neck fractures from trochanteric fractures in postmenopausal women. Osteoporos Int 2002; 13: 69-73.
6. Mautalen CA, Vega EM, Einhorn TA,. Are the etiologies of cervical and trochanteric hip fractures different? [review]. Bone 1996; 18: 133S-7S.
7. Vega E, Mautalen C, Gomez H, Garrido A, Melo L, Sahores AO,. Bone mineral density in patients with cervical and trochanteric fractures of the proximal femur. Osteoporos Int 1991; 1: 81-6.
8. Fox KM, Cummings SR, Williams E, Stone K,. Femoral neck and intertrochanteric fractures have different risk factors: a prospective study. Osteoporos Int 2000; 11: 1018-23.
9. Lin HP, Deng CY, Chou P,. Diagnosis and treatment delay among pulmonary tuberculosis patients identified using the Taiwan reporting enquiry system, 2002-2006. BMC Public Health 2009; 9: 55.
10. Chow SN, Huang CC, Lee YT,. Demographic characteristics and medical aspects of menopausal women in Taiwan. J Formos Med Assoc 1997; 96: 806-11.
11. Ekblom-Kullberg S, Kautiainen H, Alha P, Helve T, Leirisalo-Repo M, Julkunen H,. Reproductive health in women with systemic lupus erythematosus compared to population controls. Scand J Rheumatol 2009; 38: 375-80.
12. Mak A, Lim JQ, Liu Y, Cheak AA, Ho RC,. Significantly higher estimated 10-year probability of fracture in lupus patients with bone mineral density comparable to that of healthy individuals. Rheumatol Int 2013; 33: 299-307.
13. Lee C, Almagor O, Dunlop DD, Manzi S, Spies S, Ramsey-Goldman R,. Self-reported fractures and associated factors in women with systemic lupus erythematosus. J Rheumatol 2007; 34: 2018-23.
14. Karim R, Dell RM, Greene DF, Mack WJ, Gallagher JC, Hodis HN,. Hip fracture in postmenopausal women after cessation of hormone therapy: results from a prospective study in a large health management organization. Menopause 2011; 18: 1172-7.
15. Fisher AA, Srikusalanukal W, Davis MW, Smith PN,. Clinical profiles and risk factors for outcomes in older patients with cervical and trochanteric hip fracture: similarities and differences. J Trauma Manag Outcomes 2012; 6: 2.
16. Seeman E,. The structural basis of bone fragility in men. Bone 1999; 25: 143-7.
17. Kalla AA, Fataar AB, Jessop SJ, Bewerunge L,. Loss of trabecular bone mineral density in systemic lupus erythematosus. Arthritis Rheum 1993; 36: 1726-34.
18. Formiga F, Moga I, Nolla JM, Pac M, Mitjavila F, Roig-Escofet D,. Loss of bone mineral density in premenopausal women with systemic lupus erythematosus. Ann Rheum Dis 1995; 54: 274-6.
19. Houssiau FA, Lefebvre C, Depresseux G, Lambert M, Devogelaer JP, Nagant de Deuxchaisnes C,. Trabecular and cortical bone loss in systemic lupus erythematosus. Br J Rheumatol 1996; 35: 244-7.
20. Kannus P, Parkkari J, Sievanen H, Heinonen A, Vuori I, Jarvinen M,. Epidemiology of hip fractures. Bone 1996; 18 Suppl: 57S-63S.
21. Alele JD, Kamen DL, Hunt KJ, Ramsey-Goldman R,. Bone geometry profiles in women with and without SLE. J Bone Miner Res 2011; 26: 2719-26.
22. Cauley JA, Lui LY, Genant HK, Salamone L, Browner W, Fink HA, et al. Risk factors for severity and type of the hip fracture. J Bone Miner Res 2009; 24: 943-55.
23. Jacobs J, Korswagen LA, Schilder AM, van Tuyl LH, Dijkmans BA, Lems WF, et al. Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus. Osteoporos Int 2012. E-pub ahead of print.
24. Boyanov M, Robeva R, Popivanov P,. Bone mineral density changes in women with systemic lupus erythematosus. Clin Rheumatol 2003; 22: 318-23.
25. Kaji H, Yamauchi M, Chihara K, Sugimoto T,. Glucocorticoid excess affects cortical bone geometry in premenopausal, but not postmenopausal, women. Calcif Tissue Int 2008; 82: 182-90.
26. Tang XL, Qin L, Kwok AW, Zhu TY, Kun EW, Hung VW, et al. Alterations of bone geometry, density, microarchitecture, and biomechanical properties in systemic lupus erythematosus on long-term glucocorticoid: a case-control study using HR-pQCT. Osteoporos Int 2012. E-pub ahead of print.
27. Crabtree N, Loveridge N, Parker M, Rushton N, Power J, Bell KL, et al. Intracapsular hip fracture and the region-specific loss of cortical bone: analysis by peripheral quantitative computed tomography. J Bone Miner Res 2001; 16: 1318-28.
28. Katsifis GE, Tzioufas AG,. Ovarian failure in systemic lupus erythematosus patients treated with pulsed intravenous cyclophosphamide. Lupus 2004; 13: 673-8.
29. Schwartz AV, Vittinghoff E, Bauer DC, Hillier TA, Strotmeyer ES, Ensrud KE, et al. Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA 2011; 305: 2184-92.
30. Vestergaard P, Rejnmark L, Mosekilde L,. Fracture risk in patients with chronic lung diseases treated with bronchodilator drugs and inhaled and oral corticosteroids. Chest 2007; 132: 1599-607.
31. Dam TT, Harrison S, Fink HA, Ramsdell J, Barrett-Connor E,. Bone mineral density and fractures in older men with chronic obstructive pulmonary disease or asthma. Osteoporos Int 2010; 21: 1341-9.
32. De Vries F, Pouwels S, Bracke M, Leufkens HG, Cooper C, Lammers JW, et al. Use of β-2 agonists and risk of hip/femur fracture: a population-based case-control study. Pharmacoepidemiol Drug Saf 2007; 16: 612-9.
33. Sennerby U, Melhus H, Gedeborg R, Byberg L, Garmo H, Ahlbom A, et al. Cardiovascular diseases and risk of hip fracture. JAMA 2009; 302: 1666-73.
34. Pouwels S, Lalmohamed A, Leufkens B, de Boer A, Cooper C, van Staa T, et al. Risk of hip/femur fracture after stroke: a population-based case-control study. Stroke 2009; 40: 3281-5.
35. Kesmezacar H, Ayhan E, Unlu MC, Seker A, Karaca S,. Predictors of mortality in elderly patients with an intertrochanteric or a femoral neck fracture. J Trauma 2010; 68: 153-8.
36. Taiwan Cancer Registry. 2009. In Chinese. URL: http://tcr.cph.ntu.edu.tw/ uploadimages/Sur-Breast.pdf.
37. Crabtree NJ, Kroger H, Martin A, Pols HA, Lorenc R, Nijs J, et al. Improving risk assessment: hip geometry, bone mineral distribution and bone strength in hip fracture cases and controls. The EPOS study: European Prospective Osteoporosis Study. Osteoporos Int 2002; 13: 48-54.
38. Takada J, Katahira G, Iba K, Yoshizaki T, Yamashita T,. Hip structure analysis of bisphosphonate-treated Japanese postmenopausal women with osteoporosis. J Bone Miner Res 2011; 29: 458-65.
39. Boonen S, Bouillon R, Haentjens P, Vanderschueren D,. Optimizing the benefits of bisphosphonates in osteoporosis: the importance of appropriate calcium intake [review]. Treat Endocrinol 2006; 5: 375-83.
40. Rhee Y, Kang M, Min Y, Byun D, Chung Y, Ahn C, et al. Effects of a combined alendronate and calcitriol agent (Maxmarvil) on bone metabolism in Korean postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study. Osteoporos Int 2006; 17: 1801-7.
41. Yeap SS, Fauzi AR, Kong NC, Halim AG, Soehardy Z, Rahimah I, et al. A comparison of calcium, calcitriol, and alendronate in corticosteroid-treated premenopausal patients with systemic lupus erythematosus. J Rheumatol 2008; 35: 2344-7.
42. Grossman JM, Gordon R, Ranganath VK, Deal C, Caplan L, Chen W, et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken) 2010; 62: 1515-26.